What is exocrine pancreatic insufficiency (EPI)?

EPI is the failure of the pancreas to produce enough digestive enzymes, causing maldigestion and malabsorption. Clinical signs do not appear until more than 90% of the pancreatic acinar cells are lost, so by the time a dog shows symptoms the pancreas is already nearly gone — which is why the disease is diagnosed late.

Which breeds are most at risk?

German Shepherd Dogs are by far the most predisposed, followed by Rough Collies, Chow Chows and Cavalier King Charles Spaniels. In German Shepherds the cause is pancreatic acinar atrophy (an immune-mediated destruction), and signs most commonly appear between 6 months and 6 years of age.

What are the classic signs of EPI?

In dogs the hallmark is weight loss despite a ravenous appetite, with small-intestinal diarrhea and voluminous, greasy, foul-smelling stools. Cats are different — they often show only weight loss. The 'eating well but wasting away' combination is the clue that points to EPI.

How is EPI treated and what is the prognosis?

With pancreatic enzyme replacement, an easily digestible low-residue diet, and cobalamin (vitamin B12) supplementation when needed. Most dogs respond well, and prolonged survival is likely if clinical remission is achieved — so the key is getting the diagnosis right and starting enzyme therapy.

Canine Exocrine Pancreatic Insufficiency: The TLI Test

Q: How is EPI diagnosed?

With the trypsin-like immunoreactivity (TLI) test, the gold standard. A serum TLI of 5.5 µg/L or lower in dogs (8.0 µg/L or lower in cats) confirms EPI. TLI is species-specific, so it is not affected by the (usually porcine) enzyme supplements a dog may already be taking.

Q: What is subclinical EPI?

Some German Shepherds have a severely low TLI and little pancreatic tissue yet show no or only intermittent signs. TLI can fall before clinical disease appears, so a low value in an at-risk breed can precede symptoms — a reason to test proactively rather than waiting for the dog to waste away.

TL;DR — Exocrine pancreatic insufficiency (EPI) is the quiet destruction of the pancreas’s digestive-enzyme factories, and it is a German Shepherd’s disease first and foremost. The tell-tale sign is the paradox: a dog with a ravenous appetite that is wasting away, passing voluminous greasy stools. The reason it is caught late is built into the biology — clinical signs do not appear until >90% of acinar cells are gone. The test is the TLI (trypsin-like immunoreactivity): a value of ≤5.5 µg/L in dogs confirms EPI, and because TLI is species-specific, it stays accurate even if the dog is already on porcine enzyme supplements. The payoff of a correct diagnosis is real: with enzyme replacement, most dogs achieve clinical remission and prolonged survival.

In Plain Terms

The pancreas has two jobs: make hormones (insulin) and make digestive enzymes. EPI is the failure of the enzyme side. Without those enzymes, food passes through undigested — the dog eats and eats but cannot absorb the calories, so it wastes away despite a huge appetite. The cruel part is that the pancreas has enormous reserve: symptoms only appear when more than 90% of the enzyme-making cells are already destroyed.

The Paradox That Names the Disease

The classic EPI patient is a young-to-middle-aged German Shepherd that:

Eats voraciously — often more than ever.
Loses weight anyway — the food is not being absorbed.
Passes voluminous, greasy, foul-smelling stools — undigested fat and nutrients.

That combination — “eating well but wasting away” — is the single most useful clue in all of small-animal gastroenterology. When you see it, EPI jumps to the top of the differential, especially in the predisposed breeds.

The Breed Map

Breed	Relative risk	Cause
German Shepherd	Highest	Pancreatic acinar atrophy (immune-mediated)
Rough Collie	High	Acinar atrophy
Chow Chow	Elevated	Acinar atrophy
Cavalier King Charles Spaniel	Elevated	Acinar atrophy

In German Shepherds the cause is pancreatic acinar atrophy — a progressive, immune-mediated destruction of the acinar tissue — and signs most commonly emerge between 6 months and 6 years of age. In other breeds and in cats, chronic pancreatitis is the more common cause.

The TLI Test: Why It Is the Gold Standard

The trypsin-like immunoreactivity (TLI) test quantifies the pancreatic enzyme output directly, and it has two properties that make it the definitive test:

Diagnostic threshold — a serum TLI of ≤5.5 µg/L in dogs (≤8.0 µg/L in cats) confirms EPI.
Species-specific — because the assay measures the dog’s own trypsinogen, it is unaffected by the porcine enzyme supplements a dog may already be taking. You can test a dog that was started on enzymes before diagnosis and still get an accurate answer.

There is no meaningful point-of-care substitute for TLI — it is a reference-laboratory test. The practical implication is that the diagnosis often rides on correctly recognising the clinical picture and sending the sample, rather than on an in-house number.

Subclinical EPI: The Proactive Case

A subtlety worth knowing: some German Shepherds have a severely low TLI and little pancreatic tissue, yet show no signs or only intermittent ones. The biochemical disease can precede the clinical disease — a low TLI can be measured before the dog starts wasting away.

For a breeder or owner of an at-risk breed, this is an argument for proactive testing: catching a falling TLI in a young adult German Shepherd, before the >90% cell-loss threshold is crossed, means starting enzyme support while the dog is still healthy — not after it has lost a third of its body weight.

Treatment and Prognosis

The treatment is straightforward and effective:

Pancreatic enzyme replacement with every meal.
An easily digestible, low-residue diet.
Cobalamin (vitamin B12) supplementation when levels are low (common, since EPI often impairs B12 absorption).

The prognosis is good — most dogs respond well to therapy, and prolonged survival is likely if clinical remission is achieved. The gap between a good and a poor outcome is almost entirely diagnostic: recognise the paradox, send the TLI, and start enzymes early.

How the Test Runs

Recognise the paradox — ravenous appetite + weight loss + greasy stools, especially in a German Shepherd.
Draw blood for a serum TLI (reference laboratory; species-specific assay).
A value ≤5.5 µg/L confirms EPI.
Start enzyme replacement + dietary management + B12 if needed, then monitor weight and stool.

FAQ

What is EPI?

Failure of the pancreas to produce digestive enzymes. Signs appear only after >90% of acinar cells are lost — so it is diagnosed late.

How is EPI diagnosed?

With the TLI test — a value ≤5.5 µg/L (dog) or ≤8.0 µg/L (cat) confirms EPI. It is species-specific, so enzymes don’t interfere.

Which breeds are at risk?

German Shepherds first, then Rough Collies, Chow Chows, Cavaliers. Signs typically 6 months–6 years of age.

What are the classic signs?

Weight loss despite a ravenous appetite (the >90% cell-loss paradox), with voluminous greasy stools. Cats often show only weight loss.

What is subclinical EPI?

A TLI ≤5.5 µg/L before clinical signs — some German Shepherds have the biochemistry but no symptoms, an argument for proactive testing.

Treatment and prognosis?

Enzyme replacement + low-residue diet + B12. Most respond well, and prolonged survival is likely if clinical remission is achieved.

Key Takeaways

The paradox is the clue — ravenous appetite + weight loss + greasy stools = EPI (>90% acinar loss) until proven otherwise, especially in a German Shepherd.
>90% is the threshold — signs don’t appear until >90% of acinar cells are gone, which is why the disease is caught late.
TLI is the gold standard — ≤5.5 µg/L (dog) confirms EPI, and it is species-specific, so enzyme supplements don’t interfere.
Subclinical disease exists — a TLI ≤5.5 µg/L can precede symptoms in at-risk breeds; proactive testing catches it early.
The prognosis is good if caught — enzyme replacement achieves clinical remission and prolonged survival. The gap is diagnostic (a TLI ≤5.5 µg/L), not therapeutic.

References

Batchelor DJ, et al. Prognostic factors in canine exocrine pancreatic insufficiency. J Vet Intern Med. 2007;21(1):54-60.
Westermarck E, Wiberg M. Exocrine pancreatic insufficiency in the dog. Vet Clin North Am Small Anim Pract.
Merck Veterinary Manual — Exocrine Pancreatic Insufficiency in Dogs and Cats.

This content is for educational and product-selection purposes only. It is not a substitute for veterinary diagnosis — a dog with suspected EPI should be evaluated by a veterinarian. TLI is a reference-laboratory test; confirm reference ranges with your laboratory. Product specifications are as published by Migibio (Guangzhou Magic Biotech Co., Ltd.) and may change.